Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection. The Food and Drug Administration (FDA) has approved Erzofri ® (paliperidone palmitate) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback